Mindray Medical Profit to Drop 30% on Weaker Revenue

Edgen Stock

·Mar 30 2026, 12:35

Share to

Share to

Copy link

Key Takeaways

Mindray Medical released a challenging 2025 financial forecast, signaling significant headwinds. The company reported a substantial 30.28% drop in net profit and a 9.38% fall in revenue, raising investor concerns about its growth trajectory and market position.

Profit Plunges: The company's 2025 net profit is projected to be 8.136 billion yuan, a 30.28% decrease from the previous year.
Revenue Declines: Annual revenue is expected to fall by 9.38% to 33.282 billion yuan, indicating weakening sales performance.
Shareholder Dividend: Despite the downturn, Mindray plans to issue a cash dividend of 3.1 yuan per 10 shares to its shareholders.

Net Profit Plunges 30.28% in 2025

Mindray Medical announced a significant downturn in its 2025 financial outlook, with net profit projected to fall by 30.28% year-over-year to 8.136 billion yuan. This steep decline points to substantial challenges in profitability and operational efficiency for the medical device manufacturer.

The profit warning was accompanied by a projected 9.38% decrease in annual revenue, which is expected to total 33.282 billion yuan. The concurrent slide in both top-line revenue and bottom-line profit suggests broad-based pressure on the company's core business segments and raises questions about its near-term market position.

Company Proposes 3.1 Yuan Dividend Despite Headwinds

In an effort to maintain shareholder confidence, Mindray's board proposed a cash dividend of 3.1 yuan (inclusive of tax) for every 10 shares held. This distribution comes as a signal to investors that the company is committed to returning capital even as it navigates a difficult financial period.

The severe drop in projected earnings and revenue is highly likely to trigger a negative market reaction, placing downward pressure on Mindray Medical's stock price. Investors will be closely watching for management's explanation for the performance decline and its strategy to stabilize the business.